Selected research
Market Structure
Global Methotrexate Injection Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032
Market perspective
The global Methotrexate Injection market is projected to grow from US$ million in 2026 to US$ million by 2032, implying a CAGR of % over 2026-2032.
The US & Canada market for Methotrexate Injection is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.
The Europe market for Methotrexate Injection is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.
Read the full market overview
The Asia Pacific market for Methotrexate Injection is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.
The China market for Methotrexate Injection is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.
Leading global manufacturers of Methotrexate Injection include Accord, Get Well Pharmaceutical, Hikma, Fresenius Kabi, Guangdong Lingnan Pharma, Hengrui Medicine, Pfizer, Mylan and Qilu Pharmaceutical, among others. In 2025, the top three vendors together accounted for approximately % of global revenue.
This report provides an overview of the global Methotrexate Injection market in terms of sales, revenue, and price, analyzing global market trends using historical revenue and sales data for 2021-2025, estimates for 2026, and projected CAGRs through 2032.
The study covers key producers of Methotrexate Injection and sales in major regions and countries, assesses future market potential, and highlights priority regions and countries for segmenting the market into sub-sectors, with country-specific market value data for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, the Middle East, Africa, and other countries.
The report also presents Methotrexate Injection sales, revenue, market share, and industry ranking for the main manufacturers for 2021-2026, identifies the major stakeholders in the global market, and analyzes their competitive landscape and market positioning based on recent developments and segmental revenues.
In addition, the report analyzes segment data by Type and Application—covering sales, revenue, and price—for 2021-2032, and evaluates and forecasts the Methotrexate Injection market size, projected growth trends, production technologies, key applications, and end-use industries.
Methotrexate Injection Segment by Company
Accord
Get Well Pharmaceutical
Hikma
Fresenius Kabi
Guangdong Lingnan Pharma
Hengrui Medicine
Pfizer
Mylan
Qilu Pharmaceutical
Shanxi Pude Pharma
Sichuan Huiyu Pharma
Teva
Youcare Pharmaceutical Group
Methotrexate Injection Segment by Type
Preservative-Free
With Preservative
Methotrexate Injection Segment by Application
Specialty Clinic
Hospital
Recovry Center
Methotrexate Injection Segment by Region
North America
United States
Canada
Europe
Germany
France
U.K.
Italy
Netherlands
Nordic Countries
Asia-Pacific
China
Japan
South Korea
India
Australia
China Taiwan
Southeast Asia
South America
Mexico
Brazil
Argentina
Middle East & Africa
Turkey
Saudi Arabia
UAE
Study Objectives
1. To analyze and research the global status and future forecast, involving, production, value, consumption, growth rate (CAGR), market share, historical and forecast.
2. To present the key manufacturers, capacity, production, revenue, market share, and Recent Developments.
3. To split the breakdown data by regions, type, manufacturers, and Application.
4. To analyze the global and key regions market potential and advantage, opportunity and challenge, restraints, and risks.
5. To identify significant trends, drivers, influence factors in global and regions.
6. To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.
Reasons to Buy This Report
1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Methotrexate Injection market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.
2. This report will help stakeholders to understand the global industry status and trends of Methotrexate Injection and provides them with information on key market drivers, restraints, challenges, and opportunities.
3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in volume and value), competitor ecosystem, new product development, expansion, and acquisition.
4. This report stays updated with novel technology integration, features, and the latest developments in the market.
5. This report helps stakeholders to gain insights into which regions to target globally.
6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Methotrexate Injection.
7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.
Chapter Outline
Chapter 1: Provides an overview of the Methotrexate Injection market, including product definition, global market growth prospects, market size, sales, and average price forecasts (2021-2032).
Chapter 2: Provides the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 3: Detailed analysis of Methotrexate Injection manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, etc.
Chapter 4: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: Sales of Methotrexate Injection in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space of each country in the world.
Chapter 7: Revenue of Methotrexate Injection in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space of each country in the world.
Chapter 8: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 9: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 10: Concluding Insights of the report
More report detail
Tables and figures
Scope & coverage.
Types
- Preservative-Free
- With Preservative
Applications
- Specialty Clinic
- Hospital
- Recovry Center
Companies covered
- Accord
- Get Well Pharmaceutical
- Hikma
- Fresenius Kabi
- Guangdong Lingnan Pharma
- Hengrui Medicine
- Pfizer
- Mylan
- Qilu Pharmaceutical
- Shanxi Pude Pharma
- Sichuan Huiyu Pharma
- Teva
- Youcare Pharmaceutical Group
Inside the report.
1 Market Overview
- 1.1 Product Definition
- 1.2 Global Methotrexate Injection Market Size, 2021 VS 2025 VS 2032
- 1.3 Global Methotrexate Injection Market Size Estimates and Forecasts (2021-2032)
- 1.4 Global Methotrexate Injection Sales Estimates and Forecasts (2021-2032)
- 1.5 Global Methotrexate Injection Market Average Price (2021-2032)
- 1.6 Assumptions and Limitations
- 1.7 Study Goals and Objectives
2 Global Methotrexate Injection Market Dynamics
- 2.1 Methotrexate Injection Industry Trends
- 2.2 Methotrexate Injection Industry Drivers
- 2.3 Methotrexate Injection Industry Opportunities and Challenges
- 2.4 Methotrexate Injection Industry Restraints
3 Methotrexate Injection Market by Manufacturers
- 3.1 Global Methotrexate Injection Revenue by Manufacturers (2021-2026)
- 3.2 Global Methotrexate Injection Sales by Manufacturers (2021-2026)
- 3.3 Global Methotrexate Injection Average Sales Price by Manufacturers (2021-2026)
- 3.4 Global Methotrexate Injection Industry Manufacturers Ranking, 2024 VS 2025 VS 2026
- 3.5 Global Methotrexate Injection Key Manufacturers Manufacturing Sites & Headquarters
- 3.6 Global Methotrexate Injection Manufacturers, Product Type & Application
- 3.7 Global Methotrexate Injection Manufacturers Establishment Date
- 3.8 Market Competitive Analysis
- 3.8.1 Global Methotrexate Injection Market CR5 and HHI
- 3.8.2 Global Top 5 and 10 Methotrexate Injection Players Market Share by Revenue in 2025
- 3.8.3 2025 Methotrexate Injection Tier 1, Tier 2, and Tier 3
4 Methotrexate Injection Market by Type
- 4.1 Methotrexate Injection Type Introduction
- 4.1.1 Preservative-Free
- 4.1.2 With Preservative
- 4.2 Global Methotrexate Injection Sales by Type
- 4.2.1 Global Methotrexate Injection Sales by Type (2021 VS 2025 VS 2032)
- 4.2.2 Global Methotrexate Injection Sales by Type (2021-2032)
- 4.2.3 Global Methotrexate Injection Sales Market Share by Type (2021-2032)
- 4.3 Global Methotrexate Injection Revenue by Type
- 4.3.1 Global Methotrexate Injection Revenue by Type (2021 VS 2025 VS 2032)
- 4.3.2 Global Methotrexate Injection Revenue by Type (2021-2032)
- 4.3.3 Global Methotrexate Injection Revenue Market Share by Type (2021-2032)
5 Methotrexate Injection Market by Application
- 5.1 Methotrexate Injection Application Introduction
- 5.1.1 Specialty Clinic
- 5.1.2 Hospital
- 5.1.3 Recovry Center
- 5.2 Global Methotrexate Injection Sales by Application
- 5.2.1 Global Methotrexate Injection Sales by Application (2021 VS 2025 VS 2032)
- 5.2.2 Global Methotrexate Injection Sales by Application (2021-2032)
- 5.2.3 Global Methotrexate Injection Sales Market Share by Application (2021-2032)
- 5.3 Global Methotrexate Injection Revenue by Application
- 5.3.1 Global Methotrexate Injection Revenue by Application (2021 VS 2025 VS 2032)
- 5.3.2 Global Methotrexate Injection Revenue by Application (2021-2032)
- 5.3.3 Global Methotrexate Injection Revenue Market Share by Application (2021-2032)
6 Global Methotrexate Injection Sales by Region
- 6.1 Global Methotrexate Injection Sales by Region: 2021 VS 2025 VS 2032
- 6.2 Global Methotrexate Injection Sales by Region (2021-2032)
- 6.2.1 Global Methotrexate Injection Sales by Region (2021-2026)
- 6.2.2 Global Methotrexate Injection Sales Forecasted by Region (2027-2032)
- 6.3 North America
- 6.3.1 North America Methotrexate Injection Sales Growth Rate by Country: 2021 VS 2025 VS 2032
- 6.3.2 North America Methotrexate Injection Sales by Country (2021-2032)
- 6.3.3 U.S.
- 6.3.4 Canada
- 6.3.5 Mexico
- 6.4 Europe
- 6.4.1 Europe Methotrexate Injection Sales Growth Rate by Country: 2021 VS 2025 VS 2032
- 6.4.2 Europe Methotrexate Injection Sales by Country (2021-2032)
- 6.4.3 Germany
- 6.4.4 France
- 6.4.5 U.K.
- 6.4.6 Italy
- 6.4.7 Netherlands
- 6.5 Asia Pacific
- 6.5.1 Asia Pacific Methotrexate Injection Sales Growth Rate by Country: 2021 VS 2025 VS 2032
- 6.5.2 Asia Pacific Methotrexate Injection Sales by Country (2021-2032)
- 6.5.3 China
- 6.5.4 Japan
- 6.5.5 South Korea
- 6.5.6 Southeast Asia
- 6.5.7 India
- 6.5.8 Australia
- 6.6 South America, Middle East and Africa
- 6.6.1 South America, Middle East and Africa Methotrexate Injection Sales Growth Rate by Country: 2021 VS 2025 VS 2032
- 6.6.2 South America, Middle East and Africa Methotrexate Injection Sales by Country (2021-2032)
- 6.6.3 Brazil
- 6.6.4 South Africa
- 6.6.5 Saudi Arabia
- 6.6.6 Turkey
- 6.6.6 Argentina
- 6.6.6 UAE
- 6.6.6 Egypt
- 6.6.6 Chile
7 Global Methotrexate Injection Revenue by Region
- 7.1 Global Methotrexate Injection Revenue by Region
- 7.1.1 Global Methotrexate Injection Revenue by Region: 2021 VS 2025 VS 2032
- 7.1.2 Global Methotrexate Injection Revenue by Region (2021-2026)
- 7.1.3 Global Methotrexate Injection Revenue by Region (2027-2032)
- 7.1.4 Global Methotrexate Injection Revenue Market Share by Region (2021-2032)
- 7.2 North America
- 7.2.1 North America Methotrexate Injection Revenue (2021-2032)
- 7.2.2 North America Methotrexate Injection Revenue Share by Country: 2021 VS 2025 VS 2032
- 7.3 Europe
- 7.3.1 Europe Methotrexate Injection Revenue (2021-2032)
- 7.3.2 Europe Methotrexate Injection Revenue Share by Country: 2021 VS 2025 VS 2032
- 7.4 Asia-Pacific
- 7.4.1 Asia-Pacific Methotrexate Injection Revenue (2021-2032)
- 7.4.2 Asia-Pacific Methotrexate Injection Revenue Share by Country: 2021 VS 2025 VS 2032
- 7.5 South America, Middle East and Africa
- 7.5.1 South America, Middle East and Africa Methotrexate Injection Revenue (2021-2032)
- 7.5.2 South America, Middle East and Africa Methotrexate Injection Revenue Share by Country: 2021 VS 2025 VS 2032
8 Company Profiles
- 8.1 Accord
- 8.1.1 Accord Company Information
- 8.1.2 Accord Business Overview
- 8.1.3 Accord Methotrexate Injection Sales, Price, Revenue and Gross Margin (2021-2026)
- 8.1.4 Accord Methotrexate Injection Product Portfolio
- 8.1.5 Accord Recent Developments
- 8.2 Get Well Pharmaceutical
- 8.2.1 Get Well Pharmaceutical Company Information
- 8.2.2 Get Well Pharmaceutical Business Overview
- 8.2.3 Get Well Pharmaceutical Methotrexate Injection Sales, Price, Revenue and Gross Margin (2021-2026)
- 8.2.4 Get Well Pharmaceutical Methotrexate Injection Product Portfolio
- 8.2.5 Get Well Pharmaceutical Recent Developments
- 8.3 Hikma
- 8.3.1 Hikma Company Information
- 8.3.2 Hikma Business Overview
- 8.3.3 Hikma Methotrexate Injection Sales, Price, Revenue and Gross Margin (2021-2026)
- 8.3.4 Hikma Methotrexate Injection Product Portfolio
- 8.3.5 Hikma Recent Developments
- 8.4 Fresenius Kabi
- 8.4.1 Fresenius Kabi Company Information
- 8.4.2 Fresenius Kabi Business Overview
- 8.4.3 Fresenius Kabi Methotrexate Injection Sales, Price, Revenue and Gross Margin (2021-2026)
- 8.4.4 Fresenius Kabi Methotrexate Injection Product Portfolio
- 8.4.5 Fresenius Kabi Recent Developments
- 8.5 Guangdong Lingnan Pharma
- 8.5.1 Guangdong Lingnan Pharma Company Information
- 8.5.2 Guangdong Lingnan Pharma Business Overview
- 8.5.3 Guangdong Lingnan Pharma Methotrexate Injection Sales, Price, Revenue and Gross Margin (2021-2026)
- 8.5.4 Guangdong Lingnan Pharma Methotrexate Injection Product Portfolio
- 8.5.5 Guangdong Lingnan Pharma Recent Developments
- 8.6 Hengrui Medicine
- 8.6.1 Hengrui Medicine Company Information
- 8.6.2 Hengrui Medicine Business Overview
- 8.6.3 Hengrui Medicine Methotrexate Injection Sales, Price, Revenue and Gross Margin (2021-2026)
- 8.6.4 Hengrui Medicine Methotrexate Injection Product Portfolio
- 8.6.5 Hengrui Medicine Recent Developments
- 8.7 Pfizer
- 8.7.1 Pfizer Company Information
- 8.7.2 Pfizer Business Overview
- 8.7.3 Pfizer Methotrexate Injection Sales, Price, Revenue and Gross Margin (2021-2026)
- 8.7.4 Pfizer Methotrexate Injection Product Portfolio
- 8.7.5 Pfizer Recent Developments
- 8.8 Mylan
- 8.8.1 Mylan Company Information
- 8.8.2 Mylan Business Overview
- 8.8.3 Mylan Methotrexate Injection Sales, Price, Revenue and Gross Margin (2021-2026)
- 8.8.4 Mylan Methotrexate Injection Product Portfolio
- 8.8.5 Mylan Recent Developments
- 8.9 Qilu Pharmaceutical
- 8.9.1 Qilu Pharmaceutical Company Information
- 8.9.2 Qilu Pharmaceutical Business Overview
- 8.9.3 Qilu Pharmaceutical Methotrexate Injection Sales, Price, Revenue and Gross Margin (2021-2026)
- 8.9.4 Qilu Pharmaceutical Methotrexate Injection Product Portfolio
- 8.9.5 Qilu Pharmaceutical Recent Developments
- 8.10 Shanxi Pude Pharma
- 8.10.1 Shanxi Pude Pharma Company Information
- 8.10.2 Shanxi Pude Pharma Business Overview
- 8.10.3 Shanxi Pude Pharma Methotrexate Injection Sales, Price, Revenue and Gross Margin (2021-2026)
- 8.10.4 Shanxi Pude Pharma Methotrexate Injection Product Portfolio
- 8.10.5 Shanxi Pude Pharma Recent Developments
- 8.11 Sichuan Huiyu Pharma
- 8.11.1 Sichuan Huiyu Pharma Company Information
- 8.11.2 Sichuan Huiyu Pharma Business Overview
- 8.11.3 Sichuan Huiyu Pharma Methotrexate Injection Sales, Price, Revenue and Gross Margin (2021-2026)
- 8.11.4 Sichuan Huiyu Pharma Methotrexate Injection Product Portfolio
- 8.11.5 Sichuan Huiyu Pharma Recent Developments
- 8.12 Teva
- 8.12.1 Teva Company Information
- 8.12.2 Teva Business Overview
- 8.12.3 Teva Methotrexate Injection Sales, Price, Revenue and Gross Margin (2021-2026)
- 8.12.4 Teva Methotrexate Injection Product Portfolio
- 8.12.5 Teva Recent Developments
- 8.13 Youcare Pharmaceutical Group
- 8.13.1 Youcare Pharmaceutical Group Company Information
- 8.13.2 Youcare Pharmaceutical Group Business Overview
- 8.13.3 Youcare Pharmaceutical Group Methotrexate Injection Sales, Price, Revenue and Gross Margin (2021-2026)
- 8.13.4 Youcare Pharmaceutical Group Methotrexate Injection Product Portfolio
- 8.13.5 Youcare Pharmaceutical Group Recent Developments
9 Value Chain and Sales Channels Analysis
- 9.1 Methotrexate Injection Value Chain Analysis
- 9.1.1 Methotrexate Injection Key Raw Materials
- 9.1.2 Raw Materials Key Suppliers
- 9.1.3 Manufacturing Cost Structure
- 9.1.4 Methotrexate Injection Production Mode & Process
- 9.2 Methotrexate Injection Sales Channels Analysis
- 9.2.1 Direct Comparison with Distribution Share
- 9.2.2 Methotrexate Injection Distributors
- 9.2.3 Methotrexate Injection Customers
10 Concluding Insights
11 Appendix
- 11.1 Reasons for Doing This Study
- 11.2 Research Methodology
- 11.3 Research Process
- 11.4 Authors List of This Report
- 11.5 Data Source
- 11.5.1 Secondary Sources
- 11.5.2 Primary Sources
- 11.6 Disclaimer
GET THE RESEARCH
Choose your license.
Choose who needs access.
All options are for this report and research series.
PDF by email within 3–5 working days after payment confirmation.
Talk to an analyst